¿î¿µÀÚ ¿¬±¸¼Ò

¡Å ÀÌ°÷Àº ¾ÆÅäÇÇ¾Æ ¿î¿µÀÚ°¡ 20³â°£ÀÇ Ã¼Çè¿¡ ±âÃÊÇÏ¿© ¾ÆÅäÇÇ¿¡ ±Øº¹ ÆÁ°ú ÇØ¿ÜÃֽŠÁ¤º¸, ¿¬±¸ÀÚ·á ¹ø¿ª, Ä¡·áÁ¤º¸µîÀ» ½á³ª°¡´Â °÷ÀÔ´Ï´Ù. óÀ½¿À½Å ºÐµéÀº ºüÁü¾øÀÌ Àо½Ã±æ ¹Ù¶ø´Ï´Ù. ( º» ¿¬±¸¼ÒÀÇ ±ÛÀ» »çÀüÇã¶ô¾øÀÌ Àοë½Ã¿¡´Â ¹ýÀû Á¦À縦 ¹ÞÀ¸½Ç¼ö ÀÖ½À´Ï´Ù.)


ÀÚ·á¼ö : 244 °³, 9 ÆäÀÌÁöÁß 1 ÆäÀÌÁö Category
Á¦¸ñ : ºñŸ¹ÎD°¡ ¾ÆÅäÇÇ °¨¿°Áõ ¿¹¹æ
 
µî·ÏÀÏ: 2009-11-18 01:51:28 , Á¶È¸: 6,022

Á¦¸ñ ¾øÀ½

¾Æ·¡´Â 2002³â¿¡ ¿Ã¶ó¿Â ¾ÆÅäÇÇ¿Í ÀÎüÇ×»ýÁ¦¿¡ ´ëÇÑ ±â»ç³»¿ëÀÔ´Ï´Ù. ¾ÆÅäÇÇ¾Æ ¿î¿µÀÚ ¿¬±¸¼Ò¿¡µµ ¿Ã¸°¹Ù ÀÖ½À´Ï´Ù. °£·«È÷ ¿ä¾àÇÏ¸é ¾ÆÅäÇÇ È¯ÀÚÀÇ ´ëºÎºÐÀº Àü½Å¿¡ Ȳ»öÆ÷µµ»ó±¸±ÕÀÌ ÀÌ»ó¹ø½ÄÇÏ°í ÀÖÀ¸¸ç ÀÌ´Â ¾ÆÅäÇÇ ¾ÇÈ­ÀÇ ÁÖ¿äÀÎÀÌ´Ù. ±×·±µ¥ ¿Ö ÀÌ·¸°Ô Á¤»óÀΰú ´Þ¸® ÀÌ Æ÷µµ»ó±¸±ÕÀÌ ÀÌ»ó¹ø½ÄÇÏ°í ÀÖÀ¸³ÄÇϸé....±× ÀÌÀ¯´Â Àΰ£Ç¥ÇǼ¼Æ÷¿¡¼­ ºÐºñµÇ´Â Ç×»ýÁ¦ÀÎ µðÆæ½Å°ú Ä«ÅŸ®½ÃµòÀÌ Á¤»óÀΰú ´Þ¸® ¾ÆÅäÇÇ È¯ÀÚ¿¡°Ô´Â °ÅÀÇ ºÐºñµÇÁö ¾Ê´Â´Ù´Â °ÍÀÌ´Ù. ±×·±µ¥ ÀÚ·á°Ë»öÇÏ´Ù°¡º¸´Ï 2008³â 10¿ù¿¡ ³ª¿Â ¿¬±¸°á°ú °æ±¸¿ë ºñŸ¹ÎDÁ¦ÀçÀÇ º¹¿ëÀ¸·Î ÀÎüÇ×»ýÁ¦ÀÎ Ä«ÅŸ®½ÃµòÀÇ »ý»êÀ» Å©°Ô Áõ°¡½ÃÄÑ ÇǺΰ¨¿°À» ¸·À»¼ö ÀÖ´Ù°í ÇÑ´Ù. ´Ù½Ã¸»ÇÏ¸é ºñŸ¹ÎD¸¦ 21ÀÏ°£¸¸ º¹¿ëÇÏ¸é ¾ÆÅäÇÇ ÇǺÎÀÇ Æ¯Â¡ÀΠȲ»öÆ÷µµ»ó±¸±ÕÀÇ À̻󰨿°À» ¾ø¾Ù¼ö ÀÖ´Ù´Â ¸»ÀÌ´Ù...Áï, Áõ»óÀÌ È£ÀüµÉ ¼ö ÀÖ´Ù´Â ¸»ÀÔ´Ï´Ù... ³î¶øÁö ¾Ê½À´Ï±î??... ¾î´À °³±×¿ì¸ÕÀÇ À¯Çà¾îÀÎ 'Âü ½±ÁÒÀ×~~'°¡ ¶°¿À¸£³×¿ä.. (ÀÏ´Ü 2002³â ¿¬±¸°á°ú¸¦ õõÈ÷ Á¤µ¶Çؼ­ Àо¼¼¿ä... 2008³â¿¡ ¿¬±¸°á°ú´Â ¹Ø¿¡ À̾îÁý´Ï´Ù.)



ÇǺκ´ Ä¡·á °³³äÀÇ Çõ½Å

¾ÆÅäÇǼº ÇǺο°ÀÌ Àß ³´Áö ¾Ê´Â ÀÌÀ¯°¡ ¹àÇôÁ³´Ù.
ÀÌ·Î ÀÎÇØ ÇǺκ´ÀÇ º´ÅÂ¿Í Ä¡·á °³³äÀÌ Çõ¸íÀ» ÀÏÀ¸Å°°í  ÀÖ´Ù.
Çаè ÷´ÜÀÇ Àü¹®Áö(NEJM Oct 10, 2002)¸¦ ÅëÇØ ¹ßÇ¥µÈ ³î¶ó¿î ³»¿ëÀ» ¿ä¾àÇÏ¸é ´ÙÀ½°ú °°´Ù.

[±×¸²] ³­Ä¡¼º ¾ÆÅäÇǼº ÇǺο°


µÎ °¡Áö ¼ö¼ö²²³¢°¡ Ç®·È´Ù

¾Ù·¯Áö üÁú ÀÚ¿¡°Ô ³ªÅ¸³ª´Â ¾ÆÅäÇǼº ÇǺο°Àº Áö±Ý±îÁö µÎ °¡Áö ¼ö¼ö²²³¢¸¦ Ç®Áö ¸øÇÏ°í ÀÖ¾ú´Ù.
Çϳª´Â ¾ÆÅäÇÇ È¯ÀÚÀÇ 90%°¡ Ç×»ó Àü½Å¿¡ Æ÷µµ»ó ±¸±ÕÀ» ´ã»Ò Áö´Ï°í ÀÖ´Ù´Â Á¡À̾ú´Ù.
¶Ç Çϳª´Â ¾ÆÅäÇÇ È¯ÀÚÀÇ 30%´Â ÇǺΠ½ÀÁøÀÌ °íÁúÈ­µÇ¾î ³­Ä¡¼ºÀ̶ó´Â Á¡À̾ú´Ù. 

¹Ù·Î ÀÌ µÎ °¡Áö ¼ö¼ö²²³¢°¡ ÀÎü Ç×»ýÁ¦ °áÇÌÀ̶ó´Â »ç»ó ÃÖÃÊÀÇ º´Å ÀÌ·ÐÀ» ÅëÇØ ÇظíµÇ¹ö¸° °ÍÀÌ´Ù


»ç»ó ÃÖÃÊÀÇ Àΰ£ Ç×»ýÁ¦

Ç×»ýÁ¦¶ó ÇÔÀº Áö±Ý±îÁö´Â °õÆÎÀ̳ª ¼¼±ÕÀÌ ºÐºñÇÏ´Â ¹°Áú·Î¸¸ »ý°¢ÇØ ¿Ô´Ù.
±×·¯³ª Àΰ£µµ Ç×»ý¹°ÁúÀ» ¸¸µé¾î³»¾î º´±Õ¿¡ ´ëÇ×ÇØ ¿Ô´Ù´Â ³î¶ó¿î »ç½ÇÀÌ »ç»óÃÖÃÊ·Î ¹ß°ßµÈ °ÍÀÌ´Ù.
À̹ø¿¡ ÀÎü¿¡¼­ ¹ß°ßµÈ Àΰ£ Ç×»ýÁ¦´Â µðÆæ½Å(¥â-defensin) °ú
Ä«ÅŸ®½Ãµò(Cathelicidine)À̶ó´Â ÆéŸÀ̵å(Peptiides)¹°ÁúÀÌ´Ù.

[±×¸²] Ç¥ÇǼ¼Æ÷¿¡¼­ ¸¸µé¾îÁø ÀÎü Ç×»ýÁ¦°¡ º´±Õ¿¡ Áý°á

ÀÌ Ç×»ýÁ¦°¡ º¸Åë Á¤»óÀο¡°Ô´Â ¸¹Áö¸¸ ¾ÆÅäÇÇ È¯ÀÚÀÇ ÇǺο¡´Â Á¦·Î¿¡ °¡±õ´Ù.¶§¹®¿¡ ½ÀÁø¿¡ ¹ÙÀÌ·¯½º³ª °õÆÎÀ̳ª ¼¼±ÕµîÀÇ °¨¿°ÁõÀÌ ÇÕº´µÇ¾î ³­Ä¡¼ºÀÌ µÇ´Â °ÍÀÌ´Ù.

 

[±×¸² ¿ÞÂÊ] 

Atopic dermatitis---¾ÆÅäÇÇ ÇǺο° ȯÀÚÀÇ Ç×»ýÁ¦³óµµ
Psoriasis----------°Ç¼± ȯÀÚÀÇ Ç×»ýÁ¦ ³óµµ
HBD-2(uM)--------Ç×»ýÁ¦ µðÆæ½Å
 

[±×¸² ¿À¸¥ÂÊ] 

Atopic dermatitis---¾ÆÅäÇÇ ÇǺο°ÇÑÀÚÀÇ Ç×»ýÁ¦ ³óµµ
Psoriasis ---------°Ç¼± ȯÀÚÀÇ Ç×»ýÁ¦ ³óµµ
HBD-2(uM)--------Ç×»ýÁ¦ Ä«ÅÚ¸®½Ãµò


¾ÆÅäÇÇ Ã¼ÁúÀº ¿Ö Ç×»ýÁ¦ °áÇÌÀΰ¡?

 

T-ÀÓÆı¸

1) Á¤»óÀÎÀÇ °æ¿ì´Â °¨¿° ±ÕÀÌ Ä§ÀÔÇϸé T-ÀÓÆı¸(1Çü)°¡ ´ë·® ¹ßµ¿ÇÏ¿© Ç¥ÇÇ ¼¼Æ÷³ª À庮¼¼Æ÷¸¦ ÀÚ±ØÇÏ°ÔµÇ°í ºñ·Î¼Ò Ç¥ÇǼ¼Æ÷³ª À庮¼¼Æ÷°¡ Ç×»ýÁ¦¸¦ ¸¸µé¾î³»¾î °¨¿° ±ÕÀ» óġÇÑ´Ù.

[±×¸²] T-ÀÓÆı¸(³ì»ö)°¡ ħÀÔÀÚ¸¦ Á¦°Å

2) ±×·¯³ª ¾ÆÅäÇÇ Ã¼ÁúȯÀÚ´Â 1Çü T-ÀÓÆı¸¿Í´Â ÀüÇô ´Ù¸¥ T-ÀÓÆı¸(2Çü)ÀÌ ¹ßµ¿ÇÑ´Ù. ÀÌ ÀÓÆı¸´Â ¾Ù·¯Áö ¹ÝÀÀÀ» ÁÖµµÇϴ ȣ»ê±¸(Eosinophil)¸¦ µ¿¿øÇÏ´Â ÀÓÆı¸À̸ç ÀÌ ÀÓÆı¸´Â Ç¥ÇÇ ¼¼Æ÷·Î ÇÏ¿©±Ý  Ç×»ýÁ¦°¡ ¸¸µé¾îÁö´Â °ÍÀ» ¾ïÁ¦ÇÔÀÌ ¹ß°ßµÈ °ÍÀÌ´Ù


¸é¿ªÇÐÀÇ È¿½Ã(ü÷ãÅ) ÆĽºÆ² ÀÌ·Ð ¹«³ÊÁ®

[»çÁø] ¸¸ÀÎÀÇ °úÇÐÀÚµéÀÌ Á¸°æÇÏ´Â ¼¼±âÀÇ ´ëõÀç Pasteur

Àΰ£Àº °ñ¼ö¿¡¼­ ¸¸µé¾î³»´Â ¹éÇ÷±¸ µîÀ¸·Î º´±ÕÀ» ó¸®ÇÑ´Ù´Â °ÍÀÌ Áö±Ý±îÁöÀÇ ÀÌ·ÐÀÌ´Ù.
ÀÌ´Â 19¼¼±â ¸é¿ªÇÐÀÇ È¿½Ã ÆĽºÆ²(Pasteur)ÀÌ ÁÖâÇßµç °ñ¼ö(Bone Marrow) êªðÓÖåÀÌ¸ç ¿À´Ã³¯±îÁöµµ Áø¸®¿´´Ù.
±×·¯³ª ÀÌÁ¦ ÇǺο¡¼­ ¸¸µé¾îÁö´Â Àΰ£ Ç×»ýÁ¦°¡ ÃâÇöÇÑ °ÍÀÌ´Ù.

[±×¸²] Ç×»ýÁ¦ÀÇ È¿½Ã Æä´Ï½Ç¸°


°³¸·µÇ´Â ÀÎü Ç×»ýÁ¦ ½Ã´ë

Áö³­ ¹Ý¼¼±â Àΰ£Àº ¹Ì»ý¹°¿¡¼­ Ç×»ýÁ¦¸¦ ã¾ÆÇظ̴Ù.
±×·¯³ª ÀÌÁ¦ºÎÅÍ´Â »ý¸í°øÇÐÀûÀ¸·Î PeptidesÇü ÀÎü Ç×»ýÁ¦°¡ ´ë·® »ý»êµÇ°Ô µÈ´Ù.

[¸é¿ªÇÐ + À¯ÀüÀÚ°øÇÐ + ¹ßÈ¿°øÇÐ=»ý¸í°øÇÐ] ÀÌ ¸¸µå´Â ÀÎü Ç×»ýÁ¦ °øÀå


¿Â°® ¹Ì»ý¹°À» µÚÀûÀ̸ç Ç×»ýÁ¦¸¦ ã¾ÆÇظ̵ç Áö³­ ¹Ý¼¼±â ó·³ ÀÌÁ¦´Â ÀÎü·ÎºÎÅÍ ¿Â°® Ç×»ýÁ¦¸¦ ã¾Æ³»±â ½ÃÀÛÇÏ°Ô µÈ °ÍÀÌ´Ù.


°Ç¼±°ú ¾ÆÅäÇÇ ºñ±³

°Ç¼±

¾ÆÅäÇÇ

¾Ù·¯Áö ÇǺκ´ÀÌ ¾Æ´Ñ °Ç¼±°ú ¾ÆÅäÇǸ¦ ºñ±³Çغ» °á°ú´Â

1) ¼¼±ÕÀ̳ª ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ ÇǺΠÇÕº´ÁõÀº ¾ÆÅäÇÇ È¯ÀÚ Áß¿¡´Â 30%ÀÌ»óÀ̸鼭 ¸ðµÎ°¡ ³­Ä¡¼ºÀε¥ ºñÇØ °Ç¼±È¯ÀÚ Áß¿¡´Â ºÒ°ú 7%ÀÌÇÏ¿´´Ù.
2) ¶ÇÇÑ °Ç¼± ȯÀÚÀÇ ÇǺο¡¼­ ¹ß°ßµÈ µÎ Ç×»ýÁ¦ ³óµµ´Â ¾ÆÅäÇÇ È¯ÀÚº¸´Ù 10¹èÀÌ»óÀÌ ¹ß°ßµÇ¾úÀ¸¸ç ÃæºÐÇÑ Ç×±Õ·ÂÀ» ¹ßÈÖÇß´Ù.

±×·¯³ª ¾ÆÅäÇÇ È¯ÀÚÀÇ ÇǺο¡¼­ ¹ß°ßÇÒ ¼ö ÀÖ´Â ÀÎü Ç×»ýÁ¦´Â °ÅÀÇ ¾ø´Â °Í°ú ¸¶Âù°¡Áö¿©¼­ ¾Æ¹«·± È¿°ú¸¦ ±â´ëÇÒ ¼ö°¡ ¾ø¾ú´Ù.


¾ÆÅäÇÇ Ä¡·á Çõ½ÅÀÇ Æ÷ÀÎÆ®

1) Áö±Ý±îÁö ¾ÆÅäÇÇ Ä¡·áÀÇ ÁÖ¿ªÀº ºÎ½ÅÇÇÁú È£¸£¸óÁ¦ÀÎ ±¹¼Ò¿ë ½ºÅ×·ÎÀ̵åÁ¦Á¦¿´´Ù.
2) Ç×»ýÁ¦´Â ¾îµ¥±îÁö³ª °¨¿°ÁõÀÌ ÇÕº´µÈ °æ¿ì¿¡ ÇÑÇØ Á¦2Â÷¾àÀ¸·Î »ç¿ëÇØ¿Ô´Ù. ÁÖ·Î Æ÷µµ»ó±¸±ÕÀÌ ½ÀÁøÀ» ¾ÇÈ­½ÃÄÑ ³óÀ̳ª´Â °æ¿ì¿¡ ´ëÇØ »ç¿ëÇß´Ù.


3) ±×·¯³ª ÀÌÁ¦ºÎÅÍ´Â ¾ÆÅäÇÇȯÀÚÀÇ Æ¯Â¡ÀÌ ¸é¿ª ÀúÇÏ »óŶó´Â Á¡À» ¿ì¼±ÀûÀ¸·Î °í·ÁÇؾßÇÑ´Ù. µû¶ó¼­ º¸´Ù öÀúÇÑ °¨¿°ÁõÀÇ Ä¡·á°¡ ½ºÅ×·ÎÀÌµå ¿ä¹ý°ú ´õºÎ·¯ ½Öº®À» ÀÌ·ç°ÔµÇ¾ú´Ù.
4) ´õ±¸³ª ½ºÅ×·ÎÀ̵åÁ¦Á¦´Â ¸é¿ªÀ» ¾ïÁ¦ÇÏ´Â ÀÛ¿ëÀ» ÇÑ´Ù. µû¶ó¼­ ¾ÆÅäÇÇ È¯ÀÚÀÇ ¸é¿ªÀúÇÏ »óŸ¦ ´õ¿í ¾ÇÈ­½Ãų¼ö ÀÖ´Ù´Â Á¡ÀÌ Å« ¹®Á¦Á¡À¸·Î ´ëµÎµÈ °ÍÀÌ´Ù.
5) ´õ¿í ¹®Á¦µÇ´Â ¾ÆÅäÇǼº ÇǺο¡ ¼¼±Õ»Ó¾Æ´Ï¶ó ¹ÙÀÌ·¯½º³ª °õÆÎÀ̵µ ÇÕº´ÁõÀ» ÀÏÀ¸ÄÑ ¾ÇÈ­½ÃŲ´Ù´Â Á¡ÀÌ´Ù.

6) Áö±Ý°¡Áö ¾ÆÅäÇÇ ÇǺο°¿¡ »ç¿ëµÇ´Â Ç×»ýÁ¦´Â ¿¡¸®½º·Î¸¶À̽ŰèÅëÀ̳ª Muporocin °°Àº Ç×¼¼±Õ¿ë Ç×»ýÁ¦¿´´Ù. Á¤±ÕÀÛ¿ëÀ̰ųª Çù¹üÀ§¿´´Ù. ±×·¯³ª ¸é¿ªÀúÇÏ »óÅÂÀÇ Ç×±Õ ¿ä¹ýÀº  Á¤±Õ ÀÛ¿ëÁ¦´Â »ç¿ëÄ¡ ¾Ê´Â °ÍÀÌ ¿øÄ¢ÀÌ´Ù

µû¶ó¼­ Ç×±Õ¿ä¹ýÁ¦´Â ÇÊÈ÷ »ì±ÕÀÛ¿ëÁ¦¸¦ »ç¿ëÇØ¾ß ÇÒ °ÍÀÌ´Ù. ±× »ç¿ë·®µµ °í·®À» »ç¿ëÇÒ ¼ö ÀÖ´Â ¾ÈÀüÇÑ Ç×»ýÁ¦¿©¾ßÇÑ´Ù. (¿¹:º£Å¸¶ôŽ°è Ç×»ýÁ¦)

»Ó¸¸¾Æ´Ï¶ó ³»¼º Æ÷µµ±¸±ÕÀÌ ÁÖ¿ªÀÎÇÑ ³»¼º Æ÷µµ±¸±Õ¿¡ À¯È¿ÇÑ ±¤¹üÀ§ Ç×»ýÁ¦¸¦ ¼±Á¤ÇؾßÇÒ °ÍÀÌ´Ù.



´ÙÀ½ÀÌ 2008³â 10¿ù ¿¬±¸°á°úÀÔ´Ï´Ù.

ºñŸ¹Î D` ¾ÆÅäÇÇÇǺο° `ÇǺΰ¨¿°` ¸·´Â´Ù

ÀÔÀ¸·Î ¸Ô´Â ºñŸ¹Î D º¸ÃæÁ¦°¡ ÇǺΠº¸È£¼ººÐÀ» »ý»ê½ÃÄÑ °¡Àå ÈçÇÑ ÇüÅÂÀÇ ½ÀÁø¼ºÁúȯÀÎ ¾ÆÅäÇÇÇǺο° ȯÀÚ¿¡¼­ ÇǺΰ¨¿°À» ¿¹¹æÇϴµ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù.

8ÀÏ Ä¶¸®Æ÷´Ï¾Æ´ëÇÐ ¿¬±¸ÆÀÀÌ '¾Ë·¹¸£±â&ÀÓ»ó¸é¿ªÇÐÀú³Î'¿¡ ¹àÈù ¹Ù¿¡ ÀÇÇÏ¸é °æ±¸¿ë ºñŸ¹Î D º¸ÃæÁ¦°¡ ÇǺÎÁúȯÀÌ Àִ ȯÀÚ¿¡¼­ ¸é¿ª°è °áÇÔÀ» ±³Á¤ ÇǺΰ¨¿°À» ¸·´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù.

°ú°Å ¿¬±¸°á°ú ¸é¿ª°è °áÇԽà ÇǺΰ¡ 'cathelicidin(À§¿¡¼­ ¾ð±ÞµÈ¹Ù ÀÖÁÒ)'À̶ó´Â ¼¼±Õ ħÀÔÀ» ¸·´Â ÆéŸÀ̵带 »ý»êÇÏÁö ¸øÇÏ°Ô µÇ ÀÌ·Î ÀÎÇØ ½ÀÁøÀ» Æ÷ÇÔÇÑ °¢Á¾ ÇǺÎÁúȯ ȯÀÚ¿¡¼­ ÇǺΰ¨¿° À§ÇèÀÌ ³ô¾ÆÁö´Â °ÍÀ¸·Î ³ªÅ¸³­ ¹Ù ÀÖ´Ù.

Áߵ ÀÌ»óÀÇ ¾ÆÅäÇÇÇǺο°À» ¾Î´Â 14¸í ȯÀÚ¿Í °Ç°­ÇÑ 14¸íÀ» ´ë»óÀ¸·Î 21ÀÏ°£ ÁøÇàÇÑ À̹ø ¿¬±¸°á°ú °æ±¸¿ë ºñŸ¹Î D Á¦¸¦ 21ÀÏ°£ º¹¿ëÇÑ »ç¶÷µéÀÌ ÇǺλý°Ë°Ë»ç»ó 'cathelicidin' °áÇÔÀÌ º¸Á¤µÈ °ÍÀ¸·Î ³ªÅ¸³µ´Ù.

¿¬±¸ÆÀÀº À̹ø ¿¬±¸°á°ú "°æ±¸¿ë ºñŸ¹Î D º¹¿ëÀÌ ¾ÆÅäÇÇÇǺο° ȯÀÚ¿¡¼­ ÇǺΠ'cathelicidin' »ý»êÀ» Å©°Ô Áõ°¡½ÃÄÑ ÇǺΰ¨¿°À» ¸·À» ¼ö ÀÖ´Ù"¶ó°í ¹àÇû´Ù.


ÀÌ·±....±â»ç¿¡´Â ºñŸ¹Î D º¹¿ë·®ÀÌ ºüÁ®ÀÖ½À´Ï´Ù. ¾ó¸¶³ª º¹¿ëÇØ¾ß Çϴ°ɱî¿ä? Çؿܱâ»ç ´Ù½Ã °Ë»öÇغôõ´Ï º¹¿ë·®ÀÌ ³ª¿ÍÀֳ׿ä.


Oral Vitamin D May Help Prevent Atopic Dermatitis

A study led by researchers at the University of California, San Diego School of Medicine suggests that use of oral Vitamin D supplements bolsters production of a protective chemical normally found in the skin, and may help prevent skin infections that are a common result of atopic dermatitis, the most common form of eczema.

The study – led by Richard Gallo, M.D., Ph.D., professor of medicine and chief of the Division of Dermatology at the UCSD School of Medicine and the Dermatology section of the Veterans Affairs San Diego Healthcare System, and Tissa R. Hata, M.D., associate professor of medicine at UC San Diego – found that use of oral vitamin D appeared to correct a defect in the immune systems in patients with this skin disease. Their findings will be published in the October 3 edition of the Journal of Allergy & Clinical Immunology.

The researchers studied a small number of patients with moderate to severe atopic dermatitis, a chronic skin disease that affects 10 to 20 percent of children and one to three percent of adults. Atopic dermatitis is characterized by areas of severe itching, redness and scaling. Over time, chronic changes can occur due to constant scratching and rubbing. The condition puts patients at increased risk for skin infections by Staph aureus and the herpes and small pox viruses.

It had previously been shown that defects in the immune system interfere with the skin¡¯s ability to produce a peptide called cathelicidin, which is protective against microbial invasion. In many skin diseases, including eczema, a deficiency of cathelicidin correlates with increased infection.

Study participants (14 with atopic dermatitis and 14 without) were all given 4000 IUs of oral Vitamin D3 (cholecalciferol) per day for 21 days. Skin lesions were biopsied before and after the 21-day period. The researchers found that oral vitamin D use by the patients appeared to correct the skin¡¯s defect in cathelicidin.

¡°These results suggest that supplementation with oral vitamin D dramatically induces cathelicidin production in the skin of patients with atopic dermatitis,¡± said Hata. ¡°It also slightly elevated its production in normal skin in this study.¡±

However, the researchers caution that this was a small study and that further research is needed to evaluate the long-term effects of vitamin D supplementation, and to determine if this may be an adequate way to prevent infections in patients with atopic dermatitis.

In the past several years, vitamin D deficiency has been linked to increased rates of multiple cancers and diabetes, among other diseases, notably in studies published by UC San Diego researcher, Cedric Garland, Dr. P.H., professor with Moores UCSD Cancer Center and the Department of Family and Preventive Medicine at UC San Diego.

Additional contributors to the study include Paul Kotol, B.S., Michelle Jackson, M.D., Meggie Nguyen, B.S., Aimee Paik, M.D., Don Udall, M.D., Kimi Kanada, B.S., Kenshi Yamasaki, M.D., Ph.D., and Doru Alexandrescu, M.D., all from the UC San Diego Division of Dermatology.

Source: University of California, San Diego Health Sciences Released: Mon 06-Oct-2008


Áï,
ºñŸ¹Î D (Vitamin D3 (cholecalciferol) 4000IU(ÇϷ纹¿ë·®)¸¦ 21Àϵ¿¾È º¹¿ëÇß´õ´Ï
°ÅÀÇ ¾È³ª¿À´ø Ä«ÅŸ®½ÃµòÀ̶ó´Â Àΰ£Ç×»ýÁ¦ÀÇ ºÐºñ°¡ Á¤»óÀûÀ¸·Î ³ª¿À°Ô ±³Á¤µÇ¾ú´Ù´Â °ÍÀÔ´Ï´Ù.

´Ù¸¸ ÀÌ ¿¬±¸ÀÇ ¿¬±¸ÀÚ´Â À̹ø ¿¬±¸°¡ 14¸íÀ̶ó´Â ÀûÀº ¼ýÀÚÀÇ ¾ÆÅäÇÇ È¯ÀÚ¸¦ »ó´ë·ÎÇÑ ¿¬±¸À̱⿡.. ¶ÇÇÑ ºñŸ¹Î DÀÇ Àå±âº¹¿ë¿¡ ´ëÇÑ ¿¬±¸¿Í ¾ÆÅäÇÇ È¯ÀÚÀÇ °¨¿°¿¹¹æÀ» À§ÇÑ ÀûÀýÇÑ ¹æ¹ýÀΰ¡¿¡ ´ëÇؼ­´Â ¿¬±¸°¡ Á»´õ ÇÊ¿äÇÏ´Ù°í ¸»ÇÏ°í ÀÖ½À´Ï´Ù.

ÆÇ´Ü°ú ½ÇÇà¿©ºÎ´Â °á±¹ ¿©·¯ºÐµéÀÇ ¸òÀÔ´Ï´Ù. ÇÏÁö¸¸ ¼ºÀÎÀÌ°í Á»Ã³·³ È£ÀüµÇÁö ¾Ê´Â ºÐÀ̰ųª °¨¿°ÁõÀ¸·Î °í»ýÇϽô ºÐµéÀ̶ó¸é ÇѹøÂë ½ÃµµÇغ¼ ¸¸ÇÏÁö ¾ÊÀ»±î »ý°¢ÀÌ µì´Ï´Ù. ¹«¾ùº¸´Ù °£´ÜÇÏ°í ºñŸ¹ÎÀÌ´Ï ºÎÀÛ¿ëÀÇ °¡´É¼ºÀÌ Àû´Ù°í º¸À̱⿡....´Ü,¼ºÀο¡ ÇÑÇؼ­¸»ÀÌÁÒ. (À¯¾Æ³ª ¾î¸°ÀÌ¿¡ ´ëÇÑ ¿¬±¸°á°ú´Â ¾Æ´Ñ µí ÇÕ´Ï´Ù. Àý´ë µû¶óÇÏÁö ¸¶¼¼¿ä.) 



   



 
  ¾ÆÅäÇÇ Á¦Ç°¿¡¼­ ¹Ýº¹µÇ´Â °­·Â ½ºÅ×·ÎÀÌµå °ËÃâ¼Ò½Ä°ú °ü·ÃÇÏ¿© ¿ì¸®°¡ ÀØÁö ¸»¾Æ¾ßÇÒ »çÇ× (6)
5535 2009/07/19
  ¾Æ¿ï·¯ ÀǽÉÁ¦Ç°À» »ç¿ëÇÏ°í ÀÖ´Ù¸é.... (2)
3816 2009/07/22
242  Ú¸ ¾ÆÅäÇÇ Ä¡·áÁ¦ µàÇʷ縿 Çõ½Å¾à ÁöÁ¤ 
4765 2014/11/27
241  ¾ÈÁ¦½ºMG ¾ÆÅäÇÇ ½Å¾à 3»ó ÁøÀÔ 
1749 2014/09/04
240  '»ç³ëÇÇ-¸®Á¦³×·Ð' ¾ÆÅäÇÇÄ¡·áÁ¦ ÀÓ»ó 2»ó ¼º°ø 
2345 2014/07/15
239  ¼¼¶ó¸¶ÀÌµå ·Î¼Ç ½ÃÁ¦Ç° ¸ð´ÏÅÍ ¿ä¿ø ¸ðÁý ¾È³» 
2233 2014/01/09
238  Á¦¿ÕÀý°³ Ãâ»ê ¾ÆÀÌ, ¾Ë·¹¸£±â À§Çè 5¹è 
3508 2013/03/28
237  ¶ôÅä¹Ù½Ç·¯½º ¶÷³ë¼­½ºÀÇ ¾ÆÅäÇÇ ¿¹¹æ È¿°ú 
34302 2012/04/10
236  È¯°æºÎ¡¤»ï¼º¼­¿ïº´¿ø '¾ÆÅäÇÇ ÃѶ÷' ¹ß°£¡¦¾ÆÅäÇÇ¿Í È¯°æ¿äÀÎ »ó°ü°ü°è ÃÑÁ¤¸® 
3027 2012/02/01
235  °¡·Á¿ï¶§ »Ñ¸®´Â ¾ÆÀ̽º ¼öµùÄð·¯ Ãâ½Ã! 
2996 2011/05/23
234  ½ÅÁ¦Ç° Ãâ½Ã¿¹Á¤ ¾È³» 
2397 2011/04/13
233  ¾ÆÅäÇÏÇÏ, ÄÉÀÌ¿øµî 4°³»ç È­ÀåÇ°¼­ ºÒ¹ý ½ºÅ×·ÎÀÌµå °ËÃ⠼ҽĠ
2659 2010/12/04
232  ±âÀûÀÇ È­ÀåÇ°, ¾Ë°íº¸´Ï '½ºÅ×·ÎÀ̵å' ¹ü¹÷ 
28303 2010/10/22
231  »ç°ú ÃßÃâ¹°·Î ½ÄÇ° ¾Ë·¹¸£±â °³¼± ½Ã»ç 
2638 2010/07/06
230  ¾Ë·¹¸£±â¡¦ ¡°¾Ï ¹ßº´ ¾ïÁ¦ È¿°ú¡± ¿¬±¸ °á°ú ÀÕµû¶ó 
2437 2010/06/03
229  °ËÂû, °¡Â¥ ¾ÆÅäÇÇ Æ¯È¿¾à ÆǸŠÀÏ´ç ±â¼Ò 
9969 2010/05/14
228  ¼ö³ª¿¬ Á¦Ç°¿¡¼­ ½ºÅ×·ÎÀÌµå ¼ººÐ °ËÃ⠼ҽĠ
7291 2010/05/04
227  Ç︮ÄÚ¹ÚÅÍ±Õ Á¦°ÅÇÏ¸é ¾ÆÅäÇÇ ¾Ë·¹¸£±â ¹ß»ýÇϱ⠽±´Ù 
3327 2010/01/01
226  È²»öÆ÷µµ»ó±¸±Õ°ú ¾ÆÅäÇÇ 2ºÎ 
7525 2009/12/17
225  È²»öÆ÷µµ»ó±¸±Õ°ú ¾ÆÅäÇÇ 1ºÎ 
8121 2009/12/11
224  ÀüÆí¿¡ ÀÌ¾î ºñŸ¹Î D¿¡ ´ëÇؼ­... 
4416 2009/12/01
 ºñŸ¹ÎD°¡ ¾ÆÅäÇÇ °¨¿°Áõ ¿¹¹æ 
6022 2009/11/18
222  ÇöÀç »ç¿ëÇϽô Á¦Ç°ÀÌ ½ºÅ×·ÎÀ̵尡 ÀǽɵǴ ºÐµéÀº ¿î¿µÀÚ¿¡°Ô ¿¬¶ô¹Ù¶ø´Ï´Ù. (2)
3040 2009/07/21
221  ¿©¸§Ã¶¿¡ ÀϾ±â½¬¿î °õÆÎÀ̼º °¨¿°Áõ 
4818 2009/07/06
220   Ȳ»ç, ²É°¡·ç, Àڿܼ± °ø½À - ´ëó¹æ¹ý 
2461 2009/03/20
219  ÀӽŠÁß »ý¼± ¸ÔÀ¸¸é ¾ÆÅäÇÇ Áش٠
2566 2009/01/05
218  ¼ºÀξÆÅäÇÇ 4³â»õ 13¹è ±ÞÁõ 
2726 2008/10/07
217  ¾Æ½ºÅÚ¶ó½º ¾ÆÅäÇÇ¿¬°í 'ÇÁ·ÎÅäÇÈ' 21% ÀÌ»ó ¹ÝÀÀ 
3267 2008/08/12
216  ¹Ì±¹»ê ³ë¾ÆÅä(NOATO) Á¦Ç°¿¡¼­ ½ºÅ×·ÎÀÌµå ¼ººÐ °ËÃâ 
2947 2008/07/23
215  ¡°±¹»ê °ËÀºÄᡤÀڵΣ¬ ¾ÆÅäÇÇ¿¡ È¿°ú¡± 
4166 2008/05/31
1 [2][3][4][5][6][7][8][9]
 
Copyright 1999-2024 Zeroboard